Photo 80935730 © Kittipong Jirasukhanont | Dreamstime.com
MDX

Diasorin receives FDA 510(k) clearance for the updated syndromic panel NxTAG Respiratory Pathogen Panel v2

May 20, 2024
NxTag Respiratory Pathogen Panel (RPP) v2 is a molecular multiplex panel that detects 21 different pathogens (bacteria, viruses).
Photo 44896137 © Kts | Dreamstime.com
MDX

Next-generation sequencing in laboratory medicine

Advancements in sequencing techniques and the emergence of next-generation sequencing (NGS) technology have transformed laboratory medicine and clinical diagnosis. DNA sequencing...
Photo 80442023 © Alexey Novikov | Dreamstime.com
MDX

Molecular diagnostics research featured in the January issue of ADLM’s The Journal of Applied Laboratory Medicine

Jan. 17, 2024
Molecular diagnostics is a powerful branch of laboratory medicine that examines the fundamental genetic and biochemical components of life to provide invaluable insights into ...
Photo 8656482 © Olivier Le Queinec | Dreamstime.com
MDX

Factors to consider in molecular diagnostics testing during the preanalytical phase

Molecular diagnostics applies techniques of molecular biology to diagnose disease, as well as predict its course; select appropriate treatments; and monitor treatments’ ...
Courtesy of Revvity
MDX

Revvity launches EONIS Q system enabling faster, simplified newborn screening for SMA and SCID

Nov. 27, 2023
Molecular diagnostics workflow reduces complexity and costs for labs looking to expand newborn screening capabilities.
Courtesy of the CDC
23239
MDX

For bloodstream infection testing, don’t forget the fungal pathogens

Nov. 20, 2023
To take the test online go HERE. For more information, visit the Continuing Education tab. LEARNING OBJECTIVES Upon completion of this article, the reader will be able to: 1. ...
288372549 © Abdul Moizjaangda, 28929477 © Stylettt |Dreamstime.com
Dreamstime Xl 288372549
MDX

Molecular diagnostics (MDx) testing expands while lab supply shortages shrink

Oct. 18, 2023
The molecular diagnostics (MDx) market is estimated to be worth $16.6B in 2023, and expected to reach $28.6B by 2028, as “Rapid progress in technologies such as next-generation...
Photo courtesy of EUROIMMUN US
Photo courtesy of EUROIMMUN US
MDX

Molecular diagnostics for sensitive detection of dermatomycosis species

Aug. 24, 2023
Dermatomycosis of the hair, skin, or nails is one of the most prevalent fungal infections worldwide, affecting 20–25% of the global population.1 The condition is caused by keratinolytic...